Mineralys Therapeutics Statistics
Total Valuation
MLYS has a market cap or net worth of $920.60 million. The enterprise value is $540.75 million.
Important Dates
The last earnings date was Tuesday, August 12, 2025, after market close.
| Earnings Date | Aug 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
MLYS has 65.18 million shares outstanding. The number of shares has increased by 25.20% in one year.
| Current Share Class | 65.18M |
| Shares Outstanding | 65.18M |
| Shares Change (YoY) | +25.20% |
| Shares Change (QoQ) | +23.11% |
| Owned by Insiders (%) | 1.71% |
| Owned by Institutions (%) | 76.63% |
| Float | 43.59M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 2.58 |
| P/TBV Ratio | 2.59 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | -40.19% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$3.74M |
| Employee Count | 51 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +16.65% in the last 52 weeks. The beta is -0.30, so MLYS's price volatility has been lower than the market average.
| Beta (5Y) | -0.30 |
| 52-Week Price Change | +16.65% |
| 50-Day Moving Average | 14.13 |
| 200-Day Moving Average | 13.13 |
| Relative Strength Index (RSI) | 50.48 |
| Average Volume (20 Days) | 733,416 |
Short Selling Information
The latest short interest is 7.00 million, so 10.74% of the outstanding shares have been sold short.
| Short Interest | 7.00M |
| Short Previous Month | 7.87M |
| Short % of Shares Out | 10.74% |
| Short % of Float | 16.05% |
| Short Ratio (days to cover) | 10.35 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -203.07M |
| Pretax Income | -90.80M |
| Net Income | -190.77M |
| EBITDA | -203.01M |
| EBIT | -203.07M |
| Earnings Per Share (EPS) | -$3.49 |
Full Income StatementBalance Sheet
The company has $343.03 million in cash and n/a in debt, giving a net cash position of $343.03 million or $5.26 per share.
| Cash & Cash Equivalents | 343.03M |
| Total Debt | n/a |
| Net Cash | 343.03M |
| Net Cash Per Share | $5.26 |
| Equity (Book Value) | 341.56M |
| Book Value Per Share | 5.26 |
| Working Capital | n/a |
Full Balance SheetMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
MLYS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -25.20% |
| Shareholder Yield | -25.20% |
| Earnings Yield | -21.59% |
| FCF Yield | n/a |
Analyst Forecast
The average price target for MLYS is $27.00, which is 91.15% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $27.00 |
| Price Target Difference | 91.15% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |
